Key result
Among 31 patients undergoing spinal cord stimulation for refractory angina, 96.7% were using anti-angina medications and 83.9% were on antiplatelet or anticoagulant agents at baseline.
Why the study?
To describe pre-operative characteristics and considerations for multidisciplinary evaluation in patients undergoing spinal cord stimulation for refractory angina pectoris.
Observational (n=31)
No
Patients undergoing spinal cord stimulation for refractory angina have significant cardiovascular comorbidities, highlighting the need for comprehensive multidisciplinary pre-operative evaluation.
No takes yet. Share an insight, caveat, or question.
May support multidisciplinary pre-op evaluation in refractory angina; case series leaves open impact on outcomes.
Langford et al. (2021) conducted an observational in Refractory angina pectoris (n=31). Spinal cord stimulation was evaluated. Among 31 patients undergoing spinal cord stimulation for refractory angina, 96.7% were using anti-angina medications and 83.9% were on antiplatelet or anticoagulant agents at baseline.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: